1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow EpiCeram: new trials by email Literature Review of EpiCeram trials Research Report on EpiCeram
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seal, Stopping Eczema and Allergy Study Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care - Eczema, Infantile, Eczema | Phase 2 | Active not recruiting | Kari Nadeau, MD, PhD | 398 | 2021-06-30 | 2026-02-27 |
| Wound Healing Endpoint and Recurrence Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound | Phase 1 / Phase 2 | Completed | Sashwati Roy | 106 | 2019-01-08 | 2026-11-18 |
Bronchiolitis Obliterans Syndrome (1) · Burns (1) · Dermatitis (1) · Dermatitis, Atopic (1) · Diabetic Foot (1) · Eczema (1) · Food Hypersensitivity (1) · Pressure Ulcer (1) · Wounds and Injuries (1)
Kari Nadeau, MD, PhD (1) · Sashwati Roy (1)
United States (2) · United Kingdom (1)
Kari Nadeau, MD, PhD (1) · Sashwati Roy, PhD (1)
U01AI147462 (1)